Dave DeLucia D’80 co-founded ImmuNext with
Med School professor Randy Noelle in 2011. Their lead product, a drug to treat cancer, was licensed to Johnson and Johnson in 2012, just 18 months after starting the company. This success was accomplished without venture capital, so the founders maintained
control of the company. Dave got his entrepreneurial training from Gregg Fairbrothers in sessions like this one.